Latest Breaking News On - Asthma network - Page 15 : comparemela.com

Virtual Asthma Coaching Found to Improve Asthma Control

/PRNewswire/ Adults with uncontrolled asthma who take part in virtual asthma coaching show improved asthma control and quality of life, and experience fewer.

United statesPuerto ricoLynda mitchellGary fitzgeraldAllergy asthma network trusted messengersHealth equityAllergy asthma networkAsthma networkTrusted messengersVirtual asthma coachingAsthma coachingFrenika riversNative americanJohnson innovationsAllergy amp asthma network

Allergy & Asthma Network CEO Lynda Mitchell calls future really bright for care

Allergy & Asthma Network CEO Lynda Mitchell calls future really bright for care
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Capitol hillDistrict of columbiaUnited statesKristen dowdLynda mitchellByrichard gawelAllergy foundation of americaFood allergies foundationInformation on allergy asthma networkAllergy asthma networkAsthma networkAllergy foundationTrusted messengersAsthma day

FDA declines to approve nasal spray alternative to EpiPen

In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.

United statesRichard lowenthalPharmaceuticals onAsthma networkEuropean medicines agencyAdvisory committeeDrug administrationAllergy drugs advisory committeeCommittee for medicinal products humanMedicinal productsHuman use

FDA denies nasal spray alternative to EpiPen

In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.

United statesRichard lowenthalAdvisory committeeEuropean medicines agencyCommittee for medicinal products humanDrug administrationAsthma networkPharmaceuticals onAllergy drugs advisory committeeMedicinal productsHuman use

FDA declines to approve nasal spray alternative to EpiPen

In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.

United statesRichard lowenthalCommittee for medicinal products humanAllergy drugs advisory committeeDrug administrationPharmaceuticals onEuropean medicines agencyAdvisory committeeAsthma networkMedicinal productsHuman use